SRC and thyroid cancer: Curiously, the analysis of the thyroid cancer dataset at The Cancer Genome Atlas (GDC TCGA THCA) revealed positive, significant correlations among the RAI-treated patients, between the total administered dose of I131, SRC expression in the primary tumor (r = 0.19; p = 0.0124), and patient overall survival (OS) (r = 0.15; p = 0.0415) (Table S5).